Infanrix-Ipv+hib

Haemophilus influenzae type b conjugate vaccine (combined with diphtheria, tetanus, pertussis and inactivated poliovirus), the active ingredient in Infanrix-Ipv+hib, is a vaccine presented as a lyophilized powder for reconstitution and injectable suspension for intramuscular use. It induces active immunity against diphtheria, tetanus, pertussis, poliomyelitis and Hib disease in infants and young children.

GNH USA supplies Infanrix-Ipv+hib as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Infanrix-Ipv+hib is a combination vaccine that protects against several bacterial and viral infections.

- Diphtheria: provides immunity that prevents diphtheria infection in infants. - Tetanus: induces antibodies that protect against tetanus toxin. - Pertussis (whooping cough): stimulates immunity to reduce pertussis disease. - Poliomyelitis: generates protection against poliovirus type 3. - Haemophilus influenzae type b (Hib): prevents invasive Hib disease such as meningitis.

Infanrix-Ipv+hib may be associated with local and systemic reactions typical of injectable vaccines.

Common Side Effects: - Injection site pain: mild to moderate discomfort at the injection site. - Redness or swelling: transient erythema or edema around the injection area. - Fever: low‑grade temperature rise within 24‑48 hours. - Irritability: increased fussiness in infants after vaccination. - Loss of appetite: temporary reduction in feeding.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rapid onset of hives, airway swelling, or hypotension. - Seizures: febrile seizures occurring in the context of high fever. - Persistent high fever: fever lasting more than 48 hours. - Encephalopathy: rare inflammation of the brain. - Guillain‑Barré syndrome: very rare autoimmune neuropathy.

Before administering Infanrix-Ipv+hib, healthcare professionals should observe several precautions. - Contraindication: known severe allergy to any vaccine component or previous dose. - Precaution: moderate or severe acute illness may warrant postponement of vaccination. - Observation: monitor the patient for at least 15 minutes after injection for immediate reactions. - Immunocompromised patients: evaluate risk‑benefit, as response may be reduced. - Pregnancy: safety not established; vaccine generally not given to pregnant women unless benefits outweigh risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Infanrix-Ipv+hib can interact with other agents that affect immune response or cause hypersensitivity.

Major Interactions (Avoid): - Live attenuated vaccines: concurrent administration may reduce immune response to either vaccine. - Immunoglobulin or blood products: may interfere with vaccine efficacy if given within 2 weeks.

Moderate Interactions (Monitor Closely): - Antipyretics (acetaminophen, ibuprofen): may blunt antibody response if given prophylactically. - Corticosteroids or immunosuppressants: may diminish immunogenicity. - Antibiotics: generally no effect, but monitor for allergic cross‑reaction if penicillin allergy present.